Hanzhong Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital

发表论文 398 篇 · 总被引 3198 次 · h-index 29

代表论文

• Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial (2022 · The Lancet Oncology · 被引 69)
• Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region (2022 · The Prostate · 被引 17)
• A 30-Year, Single-Center Experience of Unilateral Adrenalectomy for Primary Bilateral Macronodular Adrenal Hyperplasia (2022 · Endocrine Practice · 被引 16)
• A retrospective study of paraganglioma of the urinary bladder and literature review (2024 · Frontiers in Surgery · 被引 9)
• Skeletal Muscle Metastasis From Renal Cell Carcinoma: A Case Series and Literature Review (2022 · Frontiers in Surgery · 被引 8)
• A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal Angiomyolipomas (2022 · Frontiers in Oncology · 被引 7)